PH19424A - 2-substituted 4 amino 6,7 dimethoxyquinolines - Google Patents

2-substituted 4 amino 6,7 dimethoxyquinolines

Info

Publication number
PH19424A
PH19424A PH29286A PH29286A PH19424A PH 19424 A PH19424 A PH 19424A PH 29286 A PH29286 A PH 29286A PH 29286 A PH29286 A PH 29286A PH 19424 A PH19424 A PH 19424A
Authority
PH
Philippines
Prior art keywords
dimethoxyquinolines
amino
substituted
Prior art date
Application number
PH29286A
Other languages
English (en)
Inventor
Simon Fraser Campbell
John David Hardstone
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH19424A publication Critical patent/PH19424A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/195—Radicals derived from nitrogen analogues of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
PH29286A 1982-07-24 1983-07-25 2-substituted 4 amino 6,7 dimethoxyquinolines PH19424A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8221457 1982-07-24

Publications (1)

Publication Number Publication Date
PH19424A true PH19424A (en) 1986-04-15

Family

ID=10531886

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29286A PH19424A (en) 1982-07-24 1983-07-25 2-substituted 4 amino 6,7 dimethoxyquinolines

Country Status (26)

Country Link
US (3) US4656174A (zh)
EP (1) EP0100200B1 (zh)
JP (1) JPS5933264A (zh)
KR (1) KR880001315B1 (zh)
AU (1) AU548036B2 (zh)
CA (1) CA1255670A (zh)
CS (1) CS247073B2 (zh)
DD (1) DD211555A5 (zh)
DE (1) DE3371336D1 (zh)
DK (1) DK166821B1 (zh)
ES (1) ES8504131A1 (zh)
FI (1) FI78296C (zh)
GR (1) GR79603B (zh)
HK (1) HK32289A (zh)
HU (1) HU190907B (zh)
IE (1) IE55798B1 (zh)
IL (1) IL69311A (zh)
NO (1) NO171594C (zh)
NZ (1) NZ204996A (zh)
PH (1) PH19424A (zh)
PL (1) PL139498B1 (zh)
PT (1) PT77082B (zh)
SG (1) SG6489G (zh)
SU (2) SU1251801A3 (zh)
YU (1) YU42628B (zh)
ZA (1) ZA835355B (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
GB8716972D0 (en) * 1987-07-17 1987-08-26 Pfizer Ltd Treatment of cardiac arrhythmias
GB8719378D0 (en) * 1987-08-15 1987-09-23 Pfizer Ltd Antiarrythmic agents
US4882337A (en) * 1988-08-12 1989-11-21 Pfizer Inc. Tetrahydroisoquinoline antiarrhythmic agents
US5304554A (en) * 1990-04-27 1994-04-19 Emory University 4-[(alkyl or dialkyl)amino]quinolines and their method of preparation
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
TW304945B (zh) * 1992-06-27 1997-05-11 Hoechst Ag
RU2118322C1 (ru) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
GB9514465D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514464D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
NZ325248A (en) 1995-12-23 1999-09-29 Pfizer Res & Dev Quinoline and quinazoline compounds useful in therapy
YU49898A (sh) 1996-05-10 2000-03-21 Icos Corporation Hemijska jedinjenja
GB9700504D0 (en) * 1997-01-11 1997-02-26 Pfizer Ltd Pharmaceutical compounds
GB9708917D0 (en) * 1997-05-01 1997-06-25 Pfizer Ltd Compounds useful in therapy
GB9711650D0 (en) * 1997-06-05 1997-07-30 Pfizer Ltd Compounds useful in therapy
MXPA03000458A (es) 2000-07-20 2004-06-02 Neurogen Corp Ligandos receptores de capsaicina.
DE10035928A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
EP1178036A1 (en) * 2000-08-04 2002-02-06 Aventis Cropscience S.A. Fungicidal phenylimidate derivatives
US6900220B2 (en) 2001-01-02 2005-05-31 Syntex (U.S.A.) Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
KR100420663B1 (ko) * 2001-01-09 2004-03-02 주식회사 켐온 퀴놀린 유도체, 그의 제조방법 및 그를 포함하는 약학적조성물
US6734303B2 (en) 2001-05-18 2004-05-11 Pfizer Inc. Process for the production of quinazolines
US7084156B2 (en) * 2001-11-27 2006-08-01 Merck & Co., Inc. 2-Aminoquinoline compounds
CN102743382B (zh) * 2005-09-19 2016-12-07 诺伊罗纳森特公司 刺激神经形成和抑制神经元变性的方法和组合物
AU2013211455B2 (en) * 2005-09-19 2017-12-07 Neuronascent, Inc. Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
EP2101772B1 (en) * 2006-12-06 2012-04-25 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
WO2010107488A1 (en) 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
ES2584702T3 (es) 2012-06-20 2016-09-28 Novartis Ag Moduladores de ruta del complemento y usos de los mismos
TWI649308B (zh) * 2013-07-24 2019-02-01 小野藥品工業股份有限公司 喹啉衍生物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB890533A (en) * 1959-11-09 1962-03-07 Allen & Hanburys Ltd Improvements in or relating to heterocyclic quaternary ammonium salts
CH414637A (de) * 1962-08-31 1966-06-15 Geigy Ag J R Verfahren zur Herstellung von Carbostyrilderivaten
US3272824A (en) * 1962-12-06 1966-09-13 Norwich Pharma Co 4-amino-6, 7-di(lower) alkoxyquinolines
US3542785A (en) * 1967-05-15 1970-11-24 Ciba Geigy Corp 2-hydroxy-4-aryl-quinolines
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3629418A (en) * 1969-02-14 1971-12-21 Miles Lab Process for producing an anti-depressant effect with piperazine quinolines
GB1383409A (en) * 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US4035367A (en) * 1974-09-09 1977-07-12 Sandoz, Inc. Hydroxyalkyl-substituted-amino-quinolines
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
JPS54125688A (en) * 1978-02-27 1979-09-29 Mitsubishi Yuka Yakuhin Kk Novel quinazoline derivative*its manufacture and antihypertensive drug
JPS5480372A (en) * 1977-12-12 1979-06-27 Toray Ind Inc Production of fishing rod made of carbon fiber-reinforced resin
JPS54122283A (en) * 1978-03-13 1979-09-21 Sumitomo Chem Co Ltd Novel quinazoline derivative and its preparation
JPS54128588A (en) * 1978-03-29 1979-10-05 Dainippon Pharmaceut Co Ltd Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline
JPS54128582A (en) * 1978-03-30 1979-10-05 Sumitomo Chem Co Ltd Novel quinazoline derivative and its preparation
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
DE3034001A1 (de) * 1980-09-10 1982-04-22 Hoechst Ag, 6000 Frankfurt Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung

Also Published As

Publication number Publication date
FI832658A0 (fi) 1983-07-21
IL69311A (en) 1987-01-30
ZA835355B (en) 1984-05-30
DD211555A5 (de) 1984-07-18
US4758568A (en) 1988-07-19
HU190907B (en) 1986-12-28
HK32289A (en) 1989-04-28
SU1251801A3 (ru) 1986-08-15
CA1255670A (en) 1989-06-13
GR79603B (zh) 1984-10-31
YU157283A (en) 1986-02-28
SU1340589A3 (ru) 1987-09-23
AU548036B2 (en) 1985-11-21
IE55798B1 (en) 1991-01-16
PT77082B (en) 1986-04-11
NO832688L (no) 1984-01-25
FI78296C (fi) 1989-07-10
YU42628B (en) 1988-10-31
SG6489G (en) 1989-06-09
KR840005428A (ko) 1984-11-12
KR880001315B1 (ko) 1988-07-23
PT77082A (en) 1983-08-01
CS247073B2 (en) 1986-11-13
FI78296B (fi) 1989-03-31
DE3371336D1 (en) 1987-06-11
US4686228A (en) 1987-08-11
FI832658A (fi) 1984-01-25
EP0100200B1 (en) 1987-05-06
IE831730L (en) 1984-01-24
NO171594C (no) 1993-04-07
EP0100200A1 (en) 1984-02-08
JPS5933264A (ja) 1984-02-23
AU1722283A (en) 1984-01-26
DK166821B1 (da) 1993-07-19
IL69311A0 (en) 1983-11-30
ES524320A0 (es) 1985-04-16
JPH0219112B2 (zh) 1990-04-27
DK337383A (da) 1984-01-25
US4656174A (en) 1987-04-07
PL139498B1 (en) 1987-01-31
PL243131A1 (en) 1984-12-17
NZ204996A (en) 1986-05-09
NO171594B (no) 1992-12-28
ES8504131A1 (es) 1985-04-16
DK337383D0 (da) 1983-07-22

Similar Documents

Publication Publication Date Title
PH19424A (en) 2-substituted 4 amino 6,7 dimethoxyquinolines
PH21308A (en) 3-keto-19-nor-/4,9-steroids
CS997683A2 (en) Zpusob vyroby derivatu 1,4:3,6-dianhydrohexitolu
GB2127807B (en) 2,5-piperazinediones
GB2106902B (en) 2,2-disubstituted-ethylamines
CS604984A2 (en) Zpusob tepelneho stepeni 1,2 dichloretanu
GB2160525B (en) 8,10-dideazaminopterins
GB2140007B (en) 1,8-dihydroxy-10-acyl-9-anthrones
CS620984A2 (en) Zpusob izolace 2-naftylamin-3,6,8-trisulfonove kyseliny
GB8319859D0 (en) 1,1,1-azidodinitro compounds
GB8301383D0 (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives
GB8325754D0 (en) 3-aryl-5,6-dihydro-1 4,2-oxathiazines
GB2125788B (en) 17,18-dehydro-apovincaminol
CS912983A2 (en) Zpusob vyroby l,2 dichlorethanu
PH18356A (en) Phenoxyphenyl-tetrahydro-1,3,5-thidiazin-4-ones
CS980483A2 (en) Zpusob vyroby 1,2 dichlorethanu
CS546582A1 (en) Zpusob pripravy farmakologicky ucinnych derivatu 1,4 diaminoantrachinonu
CS850684A2 (en) Zpusob vyroby neprasivych chinaxalin 1,4 di n oxidu
CS760383A1 (en) Sposob vyroby 1,1 azobisformamidu
CS378583A1 (en) Sposob vyroby 1,1 azobisformamidu
IL68335A (en) 1,3,5-triacrylylhexahydro-s-triazine derivatives
CS1024484A2 (en) Zpusob vyroby 3,4,5 trimethoxybenzonitrilu
CS812882A1 (en) Zpusob vyroby derivatu 2,5 dioxopiperazinu
CS592584A1 (en) Zpusob rafinace 2,6 xylenolu
CS623382A1 (en) Zpusob chemicke rafinace technickeho 2,6 xylenolu